CELZ

Creative Medical Technology Holdings, Inc. [CELZ] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

CELZ Stock Summary

In the News

CELZ Financial details

Company Rating
-
Market Cap
7.07M
Income
-5.23M
Revenue
9K
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
4
Optionable
No
Shortable
Yes
Earnings
10 May 2024
P/E
-0.68
Forward P/E
-
PEG
0.11
P/S
259.57
P/B
0.55
P/C
-
P/FCF
-0.66
Quick Ratio
28.43
Current Ratio
28.6
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-3.71
EPS next Y
-
EPS next Q
-
EPS this Y
-59.09%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-76.29%
Revenue last 5Y
-44.14%
Revenue Q/Q
-50%
EPS Q/Q
18.63%
-
-
-
-
SMA20
4.66%
SMA50
27.17%
SMA100
66.83%
Inst Own
-
Inst Trans
-
ROA
-78%
ROE
-69%
ROC
-0.84%
Gross Margin
67%
Oper. Margin
-41164%
Profit Margin
-39432%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
3.93-10.2812
52W High
-65%
52W Low
+16.67%
RSI
63.07
Rel Volume
0.11
Avg Volume
213.24K
Volume
23.69K
Perf Week
4.79%
Perf Month
25.9%
Perf Quarter
21.53%
Perf Half Y
-0.57%
-
-
-
-
Beta
5.037
-
-
Volatility
0.08%, 0.19%
Prev Close
0.29%
Price
3.5
Change
1.74%

Something similar

Top by Market Cap
MIX.JO
META
AAPL
AMZ.DE
VTI
Same Sector
EXAI
068760.KQ
PANACEABIO.NS
6978.HK
OTLK
Same Price Range
HEEROS.HE
002478.SZ
IMPEXFERRO.NS
000560.SZ
36B4.DE
Similar Market Cap
TORM
MTVR
SC05.DE
RWGV
YGMZ

Company Profile

Healthcare Biotechnology

Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.